 |  |  |  |  |  |  |  |
Gene Signal and Collaborators Publish GS-101 Clinical Data Suggesting Safe and Effective Inhibition of Abnormal Ophthalmic Blood Vessel Growth
Data Published in Ophthalmology Show GS-101 May Prevent Corneal Graft Rejection
Claus Cursiefen, MD, Dep. of Ophthalmology, University of Erlangen-Nürnberg, Erlangen, Germany.
Eric Viaud – CEO and Co-Founder, Gene Signal
Claus Cursiefen, MD, Dep. of Ophthalmology, University of Erlangen-Nürnberg, Erlangen, Germany.
Eric Viaud – CEO and Co-Founder, Gene Signal
To download files, right click on the links and select "save target as..."
